comparemela.com

Veritas Asset Management LLP reduced its stake in Bio-Rad Laboratories, Inc. (NYSE:BIO – Free Report) by 2.8% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 1,082,895 shares of the medical research company’s stock after selling 30,648 shares during the quarter. Bio-Rad Laboratories makes up […]

Related Keywords

United States , Canada , America , , Citigroup , Veritas Asset Management , Principal Securities Inc , Jefferies Financial Group , Royal Bank , Exchange Commission , Bio Rad Laboratories Inc , Bio Rad Laboratories , Free Report , Rad Laboratories , Asset Management , Capital Management , Get Free Report , Life Science , Bio Rad Laboratories Daily ,

© 2024 Vimarsana

comparemela.com © 2020. All Rights Reserved.